Technical Analysis for NURO - NeuroMetrix, Inc.

Grade Last Price % Change Price Change
grade F 1.97 -3.90% -0.08
NURO closed down 3.9 percent on Thursday, June 4, 2020, on 29 percent of normal volume. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down
Historical NURO trend table...

Date Alert Name Type % Chg
Expansion Pivot Sell Setup Bearish Swing Setup 0.00%
Hammer Candlestick Bullish 0.00%
Stochastic Buy Signal Bullish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
BB Squeeze + Lower Band Touch Range Contraction 0.00%
Down 3 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Fell Below 200 DMA Bearish -3.90%
Fell Below 50 DMA Bearish -3.90%

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

NeuroMetrix, Inc., a medical device company, develops and markets products for the detection, diagnosis, and monitoring of peripheral nerve and spinal cord disorders, such as those associated with carpal tunnel syndrome, lumbosacral disc disease, spinal stenosis, and diabetes. The company focuses on the diagnosis and treatment of neurological complications of diabetes, including diabetic peripheral neuropathy (DPN) and median neuropathy. Its marketed products include NC-stat DPNCheck, a device used to evaluate systemic neuropathies, such as DPN at the point-of-care; SENSUS pain therapy device, a transcutaneous electrical nerve stimulator used for chronic and intractable pain relief; and ADVANCE NCS/EMG system, a platform for the performance of traditional nerve conduction studies and invasive electromyography procedures for the assesment of CTS, low back and leg pain, and DPN, as well as consumables and accessories. The company is also developing SENTINEL device that provides sensory enhancement in the feet targeted at patients who have lost sensory perception in the lower extremities. NeuroMetrix, Inc. distributes its products directly through its direct sales force and independent sales representatives to physicians, clinics, hospitals, managed care organizations, retail health businesses, and independent distributors consisting of primary care, internal medicine, orthopedic and hand surgeons, pain medicine physicians, neurologists, physical medicine and rehabilitation, physicians, and neurosurgeons, as well as endocrinology and podiatry markets primarily in the United States, the United Kingdom, the Netherlands, and India. The company was founded in 1996 and is headquartered in Waltham, Massachusetts.
Medicine Pain Diabetes Neuroscience Pain Management Nervous System Neuromodulation Neurotechnology Neurophysiology Acute Pain Diabetic Peripheral Neuropathy Carpal Tunnel Syndrome Electrodiagnosis Peripheral Neuropathy Transcutaneous Electrical Nerve Stimulation

Is NURO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 6.2
52 Week Low 0.2518
Average Volume 1,386,718
200-Day Moving Average 2.07
50-Day Moving Average 2.13
20-Day Moving Average 2.18
10-Day Moving Average 2.14
Average True Range 0.26
ADX 33.97
+DI 25.54
-DI 21.59
Chandelier Exit (Long, 3 ATRs ) 1.91
Chandelier Exit (Short, 3 ATRs ) 2.58
Upper Bollinger Band 2.41
Lower Bollinger Band 1.95
Percent B (%b) 0.05
BandWidth 21.47
MACD Line -0.06
MACD Signal Line -0.03
MACD Histogram -0.0306
Fundamentals Value
Market Cap 3.66 Million
Num Shares 1.86 Million
EPS -19.02
Price-to-Earnings (P/E) Ratio -0.10
Price-to-Sales 0.21
Price-to-Book 0.63
PEG Ratio -0.01
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.36
Resistance 3 (R3) 2.35 2.20 2.30
Resistance 2 (R2) 2.20 2.10 2.21 2.27
Resistance 1 (R1) 2.09 2.04 2.02 2.10 2.25
Pivot Point 1.94 1.94 1.91 1.95 1.94
Support 1 (S1) 1.83 1.84 1.76 1.84 1.69
Support 2 (S2) 1.68 1.78 1.69 1.67
Support 3 (S3) 1.57 1.68 1.65
Support 4 (S4) 1.58